Literature DB >> 15223441

Diffuse pulmonary infiltrates after bone marrow transplantation: the role of open lung biopsy.

Jann-Yuan Wang1, Yih-Leong Chang, Li-Na Lee, Jen-Hau Chen, Jih-Luh Tang, Pan-Chyr Yang, Yung-Chie Lee.   

Abstract

BACKGROUND: Diffuse pulmonary infiltrates is the major complication and cause of mortality after bone marrow transplantation. We analyzed the etiologies and prognostic factors in bone marrow recipients with diffuse pulmonary infiltrates and assessed the role of open lung biopsy in managing this complication.
METHODS: Medical records of patients with diffuse pulmonary infiltrates after bone marrow transplantation were reviewed. Possible prognostic factors were analyzed by multivariate logistic regression.
RESULTS: Sixty-eight (20%) of 341 bone marrow recipients had diffuse pulmonary infiltrates and 34 died. Thirty-five underwent open lung biopsy, resulting in therapeutic changes in 22 (63%) and clinical improvement in 16 (46%). The leading diagnoses were idiopathic interstitial pneumonitis (40%) and cytomegalovirus pneumonitis (20%). Cytomegalovirus pneumonitis caused radiographically observable interstitial infiltrates exclusively and was frequently associated with hepatitis. Idiopathic interstitial pneumonitis resulted in either diffuse ground-glass opacity or interstitial infiltrates. Three (9%) patients had miliary tuberculosis. Respiratory failure (p < 0.001) and acute graft-versus-host disease (p = 0.016) were the poor prognostic factors.
CONCLUSIONS: Among bone marrow recipients, we found diffuse pulmonary infiltrates in 20% and a mortality rate of 50%. Idiopathic interstitial pneumonitis and cytomegalovirus pneumonitis were the most common causes and should be suspected in patients with diffuse interstitial infiltrates. In endemic areas, miliary tuberculosis should be suspected in bone marrow recipients with diffuse reticulonodular lesions. Respiratory failure and acute graft-versus-host disease were poor prognostic factors. By establishing a correct diagnosis, open lung biopsy led to treatment changes in about two-thirds of these patients.

Entities:  

Mesh:

Year:  2004        PMID: 15223441     DOI: 10.1016/j.athoracsur.2004.03.002

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  8 in total

1.  Metagenomic Next-Generation Sequencing Successfully Detects Pulmonary Infectious Pathogens in Children With Hematologic Malignancy.

Authors:  Dao Wang; Weilin Wang; Yanjie Ding; Miaomiao Tang; Lei Zhang; Jiao Chen; Hongliang You
Journal:  Front Cell Infect Microbiol       Date:  2022-06-28       Impact factor: 6.073

2.  Etiologies, diagnostic strategies, and outcomes of diffuse pulmonary infiltrates causing acute respiratory failure in cancer patients: a retrospective observational study.

Authors:  Hongseok Yoo; Gee Young Suh; Byeong-Ho Jeong; So Yeon Lim; Man Pyo Chung; O Jung Kwon; Kyeongman Jeon
Journal:  Crit Care       Date:  2013-07-23       Impact factor: 9.097

3.  Acute myeloid leukemia presenting with pulmonary tuberculosis.

Authors:  Merlin Thomas; Mushtak AlGherbawe
Journal:  Case Rep Infect Dis       Date:  2014-05-28

4.  Reduced incidence of interstitial pneumonitis after allogeneic hematopoietic stem cell transplantation using a modified technique of total body irradiation.

Authors:  Yun Chiang; Cheng-Hong Tsai; Sung-Hsin Kuo; Chieh-Yu Liu; Ming Yao; Chi-Cheng Li; Shang-Yi Huang; Bor-Sheng Ko; Chien-Ting Lin; Hsin-An Hou; Wen-Chien Chou; Jia-Hau Liu; Chien-Chin Lin; Shang-Ju Wu; Szu-Chun Hsu; Yao-Chang Chen; Kai-Hsin Lin; Dong-Tsamn Lin; Hsien-Tang Chou; Meng-Yu Lu; Yung-Li Yang; Hsiu-Hao Chang; Ming-Chih Liu; Xiu-Wen Liao; Jian-Kuen Wu; Sheng-Chieh Chou; Chieh-Lung Cheng; Chien-Yuan Chen; Woei Tsay; Hwei-Fang Tien; Jih-Luh Tang; Yu-Hsuan Chen
Journal:  Sci Rep       Date:  2016-11-10       Impact factor: 4.379

5.  Benefit-to-risk balance of bronchoalveolar lavage in the critically ill. A prospective, multicenter cohort study.

Authors:  Toufik Kamel; Julie Helms; Ralf Janssen-Langenstein; Achille Kouatchet; Antoine Guillon; Jeremy Bourenne; Damien Contou; Christophe Guervilly; Rémi Coudroy; Marie Anne Hoppe; Jean Baptiste Lascarrou; Jean Pierre Quenot; Gwenhaël Colin; Paris Meng; Jérôme Roustan; Christophe Cracco; Mai-Anh Nay; Thierry Boulain
Journal:  Intensive Care Med       Date:  2020-01-07       Impact factor: 17.440

6.  Infections caused by mycobacterium tuberculosis in patients with hematological disorders and in recipients of hematopoietic stem cell transplant, a twelve year retrospective study.

Authors:  Khalid Ahmed Al-Anazi; Asma Marzouq Al-Jasser; David Alan Price Evans
Journal:  Ann Clin Microbiol Antimicrob       Date:  2007-11-16       Impact factor: 3.944

Review 7.  Tuberculosis in hematopoietic stem cell transplant recipients.

Authors:  Jéssica Fernandes Ramos; Marjorie Vieira Batista; Silvia Figueiredo Costa
Journal:  Mediterr J Hematol Infect Dis       Date:  2013-11-04       Impact factor: 2.576

8.  Early predictors of mortality in children with pulmonary complications after haematopoietic stem cell transplantation.

Authors:  Yu Hyeon Choi; Hyung Joo Jeong; Hong Yul An; You Sun Kim; Eui Jun Lee; Bongjin Lee; Hyoung Jin Kang; Hee Young Shin; June Dong Park
Journal:  Pediatr Transplant       Date:  2017-10-12
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.